4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0000950170-24-048457
Director acquired 3,639,680 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Fairmount Funds Management LLC · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-25 | Exercise or conversion : show line 1 in the form | +3,639,680 | 4,018,101 | I |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-25 | Exercise or conversion : show line 2 in the form Series A Preferred Stock | −90,992 | 346,045 | I |
Loading xslF345X05/ownership.xml…